EFTA01493825.pdf

FINANCIAL TRUST COMPANY INC ACCT. For the Period I/1/13 to 1/31/13 Trade Date Type Per Unit Realized Est. settle Date Selection Method Description Quantity Amount Proceeds Tax Cost Gain/Loss Pending Sales, Maturities, Redemptions 1/31 Sale VANGUARD NATURAL RESOURCES LLC (ID: 92205F-10-6) (3,500.000) 27.75 96,982.82 (97,475.00) (492.18) S 25 1/31 Sale KERYX BIOPHARMACEUTICALS INC (ID: 492515-10-1) (1,500.000) 9.50 14,189.68 (12,735.00) 1,454.68 S 25 Total Pending Sales. Maturities. Redemptions $1.130A14.62 (61,130,710.00) (0296.3S) S Trade Date Per Unit Est. Settle Date Type Description Quantity Amount Market Cost Pending Securities Purchased 129 Purchase JPMORGAN CHASE & CO PFD 5.450% (ID: 46637G-12-4) 60,000.000 25.00 (1,500,000.00) 25 1/29 Purchase PIEDMONT NATURAL GAS CO INC (ID: 720186-10-5) 6,500.000 32.00 (208,000.00) 2/4 1/31 Purchase KERYX BIOPHARMACEUTICALS INC (ID: 492515-10-1) 1,500.000 8.49 (12,735.00) 25 1/31 Purchase VANGUARD NATURAL RESOURCES LLC (ID: 92205E-104q 3,500.000 27.85 (97,475.00) 2/5 1/31 Purchase ZOETIS INC (ID: 98978V-10-3) 25.000.000 26.00 (650.000.00) Total Pending Securities Purchased ($2,468,210.00) J.P Morgan Account Page 29 of 38 Consolidated Statement Page 32 Confidential Treatment Requested by JPMorgan JPM-SDNY-00016738 Chase CONFIDENTIAL SDNY_GM_00285936 EFTA01493825